Philadelphia, Pennsylvania--(Newsfile Corp. - April 15, 2024) - Kaskela Law LLC announces that it is investigating Tyra Biosciences, Inc. (NASDAQ: TYRA) ("Tyra") on behalf of the company's shareholders.
Since March 2024, shares of Tyra's common stock have declined from a trading value of approximately $20.00 per share to a current trading price of less than $17.00 per share, a decline of over 15% in value.
The investigation seeks to determine whether Tyra and/or the company's representatives violated the securities laws by issuing false and/or misleading statements, or by failing to disclose material information to investors, thereby causing investor losses.
Tyra shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 - 0750 or (888) 715 - 1740, or by email (skaskela@kaskelalaw.com / abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/tyra-biosciences/ , for additional information about this investigation and their legal rights and options.
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 - 1740
(484) 229 - 0750
www.kaskelalaw.com
This notice may constitute attorney advertising in certain jurisdictions.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/205476
